375 related articles for article (PubMed ID: 7842013)
41. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
Fan D; Shen Y; Kang D; Nakano I; Ozawa K
Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
[TBL] [Abstract][Full Text] [Related]
42. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors.
Tang DC; Johnston SA; Carbone DP
Cancer Gene Ther; 1994 Mar; 1(1):15-20. PubMed ID: 7621233
[TBL] [Abstract][Full Text] [Related]
43. An experimental study on rat model of parkinsonism by gene therapy.
Xu Q; Tian J; Zhang J; Yang H; Zheng S; Liu Y
Chin Med J (Engl); 1998 Feb; 111(2):154-9. PubMed ID: 10374378
[TBL] [Abstract][Full Text] [Related]
44. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.
Mandel RJ; Spratt SK; Snyder RO; Leff SE
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14083-8. PubMed ID: 9391156
[TBL] [Abstract][Full Text] [Related]
45. Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.
Imaoka T; Date I; Ohmoto T; Nagatsu T
Hum Gene Ther; 1998 May; 9(7):1093-102. PubMed ID: 9607420
[TBL] [Abstract][Full Text] [Related]
46. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
Horellou P; Vigne E; Castel MN; Barnéoud P; Colin P; Perricaudet M; Delaère P; Mallet J
Neuroreport; 1994 Dec; 6(1):49-53. PubMed ID: 7703427
[TBL] [Abstract][Full Text] [Related]
47. Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.
Li XG; Okada T; Kodera M; Nara Y; Takino N; Muramatsu C; Ikeguchi K; Urano F; Ichinose H; Metzger D; Chambon P; Nakano I; Ozawa K; Muramatsu S
Mol Ther; 2006 Jan; 13(1):160-6. PubMed ID: 16182609
[TBL] [Abstract][Full Text] [Related]
48. Efficient and sustained transgene expression in mature rat oligodendrocytes in primary culture.
Guo Z; Yang NS; Jiao S; Sun J; Cheng L; Wolff JA; Duncan ID
J Neurosci Res; 1996 Jan; 43(1):32-41. PubMed ID: 8838571
[TBL] [Abstract][Full Text] [Related]
49. A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors.
Zhang GR; Wang X; Yang T; Sun M; Zhang W; Wang Y; Geller AI
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):17-31. PubMed ID: 11113528
[TBL] [Abstract][Full Text] [Related]
50. Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system.
Wang Y; Yu L; Geller AI
Hum Gene Ther; 1999 Jul; 10(11):1763-71. PubMed ID: 10446916
[TBL] [Abstract][Full Text] [Related]
51. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
[TBL] [Abstract][Full Text] [Related]
52. Enhanced adeno-associated virus vector expression by adenovirus protein-cationic liposome complex. A novel and high efficient way to introduce foreign DNA into endothelial cells.
Zhou H; Zeng G; Zhu X; Tang J; Chen G; Huang Q; Peng T; Hu B
Chin Med J (Engl); 1995 May; 108(5):332-7. PubMed ID: 7555232
[TBL] [Abstract][Full Text] [Related]
53. Novel strategies for the selection of cells expressing human adenosine deaminase and their application in experimental gene therapy protocols.
Shen Q; Van Beusechem VW; Hendrikx PJ; Valerio D
Allergol Immunopathol (Madr); 1991; 19(1):29-31. PubMed ID: 1659164
[No Abstract] [Full Text] [Related]
54. Multi-site partitioned delivery of human tyrosine hydroxylase gene with phenotypic recovery in Parkinsonian rats.
Leone P; McPhee SW; Janson CG; Davidson BL; Freese A; During MJ
Neuroreport; 2000 Apr; 11(6):1145-51. PubMed ID: 10817582
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy for Parkinson's disease.
Horellou P; Mallet J
Mol Neurobiol; 1997 Oct; 15(2):241-56. PubMed ID: 9396012
[TBL] [Abstract][Full Text] [Related]
56. Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats.
Hida H; Hashimoto M; Fujimoto I; Nakajima K; Shimano Y; Nagatsu T; Mikoshiba K; Nishino H
Neurosci Res; 1999 Nov; 35(2):101-12. PubMed ID: 10616914
[TBL] [Abstract][Full Text] [Related]
57. Isolation of an enhancer from the rat tyrosine hydroxylase promoter that supports long-term, neuronal-specific expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system.
Gao Q; Sun M; Wang X; Geller AI
Brain Res; 2007 Jan; 1130(1):1-16. PubMed ID: 17169349
[TBL] [Abstract][Full Text] [Related]
58. A preproenkephalin-neurofilament chimeric promoter in a helper virus-free herpes simplex virus vector enhances long-term expression in the rat striatum.
Wang X; Kong L; Zhang GR; Sun M; Geller AI
Neurobiol Dis; 2004 Aug; 16(3):596-603. PubMed ID: 15262272
[TBL] [Abstract][Full Text] [Related]
59. Selective and rapid uptake of adeno-associated virus type 2 in brain.
Bartlett JS; Samulski RJ; McCown TJ
Hum Gene Ther; 1998 May; 9(8):1181-6. PubMed ID: 9625257
[TBL] [Abstract][Full Text] [Related]
60. Application of gene therapy for Parkinson's disease: nonhuman primate experience.
Bankiewicz KS; Bringas JR; McLaughlin W; Pivirotto P; Hundal R; Yang B; Emborg ME; Nagy D
Adv Pharmacol; 1998; 42():801-6. PubMed ID: 9328019
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
